Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer
Clinical trial NCT02450032 · COMPLETED
Trial details
- NCT number
- NCT02450032
- Sponsor
- Cancer Advances Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-02-01
- Primary completion
- 2001-05-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.